Clinical Trial

Clinical Performance of Withings Move ECG Software for Atrial Fibrillation Detection

Study acronym: ECG-SW1
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Withings Move ECG watch is designed to record ECG and detect automatically atrial fibrillation. The aim of this study is to validate the performance of Move ECG watch to detect atrial fibrillation compared to a reference 12-lead ECG.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-07-27.
Status change: Recruiting → Active, Not Recruiting 2026-02-17
Trial Details
NCT Number NCT04493749
Lead Sponsor Withings
Conditions Atrial Fibrillation
Enrollment 234 participants
Start Date 2019-12-20
Primary Completion 2021-03-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-18